Ascend, Xellia Announce Refunds for 340B Overcharges
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...]
*Sign up for news summaries and alerts from 340B Report